Recent News

• 08.26.2025 - Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder
• 08.22.2025 - Incannex Healthcare Authorizes $20 Million Share Repurchase Program
• 08.08.2025 - Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea
• 07.31.2025 - Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term
• 07.30.2025 - Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X
• 07.25.2025 - Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Recent Filings

• 08.26.2025 - 8-K Current report
• 08.26.2025 - EX-99.1 EX-99.1
• 08.22.2025 - EX-99.1 EX-99.1
• 08.22.2025 - 8-K Current report
• 08.08.2025 - 8-K Current report
• 08.08.2025 - EX-99.1 EX-99.1
• 07.31.2025 - 8-K Current report
• 07.31.2025 - EX-99.1 EX-99.1
• 07.30.2025 - 8-K Current report
• 07.30.2025 - EX-99.1 EX-99.1